<DOC>
	<DOCNO>NCT01836172</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy YJP-14 capsule treatment endothelial dysfunction patient diabetes mellitus .</brief_summary>
	<brief_title>YJP-14 Capsules Treatment Endothelial Dysfunction Patients With Diabetes Mellitus</brief_title>
	<detailed_description>The primary purpose study demonstrate superior effect YJP-14 three dos , 25 , 50 100 mg t.i.d endothelial dysfunction diabetes mellitus indicated mean change difference flow-mediated dilation ( FMD ) , compare placebo group treatment 12 week . The secondary purpose study divide three follow ; - Clinically significant effect YJP-14 three dos , 25 , 50 100 mg t.i.d endothelial dysfunction diabetes mellitus indicated mean change difference FMD , compare placebo group treatment 8 week . - Clinically significant effect YJP-14 three dos , 25 , 50 100 mg t.i.d insulin resistance diabetes mellitus indicated mean change difference Homeostasis Model Assessment-Insulin Resistance ( HOMA-IR ) , compare placebo group treatment 4 , 8 12 week . - Clinically significant effect YJP-14 three dos , 25 , 50 100 mg t.i.d mean change difference blood pressure diabetes mellitus , compare placebo group treatment 4 , 8 12 week . The exploratory purpose study divide two follow ; - Clinically significant effect YJP-14 three dos , 25 , 50 100 mg t.i.d blood glucose level diabetes mellitus indicate mean change difference HbA1c , compare placebo group treatment 12 week . - Clinically significant effect YJP-14 three dos , 25 , 50 100 mg t.i.d vascular stiffness diabetes mellitus indicated mean change difference blood lipid ( LDL , HDL TG ) , compare placebo group treatment 12 week .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Complications</mesh_term>
	<criteria>Adultonset DM ( define fast glucose great 125 mg/dl ongoing treatment oral hypoglycemic agent ) , Endothelial dysfunction : FMD 6.7 % , LDL cholesterol level le 140 mg/dl , Patients agree Informed Consent Form ( Key exclusion criterion ) Uncontrolled arterial hypertension ( 139/90 mmHg ) hypotension ( 80/50 mmHg ) , Severe diabetic complication : diabetic nephropathy , diabetic neuropathy , diabetic retinopathy , diabetic vascular complication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>The treatment diabetic complication</keyword>
</DOC>